New appointments at DCC: Dawn Logan-Keeffe, Tony Shaw & Alex Tzanidis
The firm is pleased to announce the following new appointments:
Dawn has joined the Trade Mark team located in our Sydney Office, but will service on a regular basis our Brisbane Office. Dawn has extensive experience in handling all aspects of Australian and New Zealand trade mark clearance, prosecution and enforcement practices. She represents a variety of clients, ranging from individuals to major companies. utilising her legal and marketing backgrounds and her in-house experience, Dawn brings a commercial awareness to the management of trade mark portfolios and works closely with marketing departments to raise the importance of trade mark issues in the brand formation process.
Dawn originally practised as a trade mark attorney in the UK and has experience both in private practice and as the IP manager for an international financial institution. She has worked in the United Arab emirates for a well known international IP law firm, where her work included both prosecution and enforcement work for clients throughout the middle east and North Africa.
Tony has joined the biotech Patent team located in our Sydney Office and has experience in the drafting and prosecution of biotechnology patent applications. He has extensive experience in the fields of molecular biology, protein chemistry and heart disease.
Tony completed his PhD at the University of Queensland before taking up a Postdoctoral Fellowship at Imperial Cancer Research Fund (now Cancer Research UK) as a joint appointment in the breast cancer biology and protein structure and function laboratories. Following that appointment Tony developed a research group when he became a lecturer at the University of London (St George’s Hospital Medical School) with funding from both the Wellcome Trust and the British Heart Foundation. Tony then accepted a British Heart Foundation Fellowship at the Department of medicine, University College before returning to Australia in 2006 after eight years in the UK.
He is the author of more than 20 refereed research papers in international journals including The Lancet, Molecular Cell, Circulation and the Journal of Biological Chemistry. Tony has been invited to contribute articles to a number of journals.
Alex has joined the biotech patent team located in Melbourne. Alex specialises in the preparation and prosecution of patent applications in the areas of cell biology, immunology, cardiology, nephrology, angiology and molecular biology. He is experienced in conducting patent oppositions and advising on patent related litigation. He also provides advice on patentability, patent infringement and validity as well as conducting IP audits.
Alex’s PhD studies investigated the role of neurohormonal factors and inflammatory cytokines in the pathophysiology of experimental end stage renal failure. upon completing his PhD, Alex accepted an invitation to pursue postdoctoral research in the area of cardiovascular disease at the Clinical Pharmacology Unit, Monash Medical School, Alfred Hospital. During this time, he collaborated extensively with research groups at Baker IDI and multinational pharmaceutical companies and has published his work internationally.
Alex has experience in handling IP matters relating to many areas of biotechnology, and has assisted local clients, including research institutes, universities and corporate entities, with patent drafting and local/overseas patent prosecution. He also has expertise in overseeing the prosecution of patent portfolios for medium to large overseas biotechnology companies.